Boston Scientific is making it easier for doctor to get radioactive TheraSphere treatments to patients when and where they need them.
4hon MSN
PDS Biotech outlines trial protocol amendment for accelerated PFS endpoint in HPV16-positive cancer
Get key insights from PDS Biotech’s Q3 2025 earnings call, including regulatory updates for PDS0101 in HPV16+ cancer and financial highlights.
MES software is transforming medical plastics manufacturing by automating compliance and enabling real-time traceability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback